The U.S. Supreme Court's unanimous ruling last week — that companies may no longer patent human genes — resonated across the cancer community, resulting in promising news for cancer patients and researchers.
The past several years of cancer research have been both exciting and promising. Recent developments have allowed us to take steps in improving many cancer treatments. I believe this momentum will continue to accelerate exponentially.
Last week's Roswellness Radio went inside Roswell Park's new Center for Personalized Medicine (CPM), a state-of-the-art facility that uses sequencing tools to provide individualized care for cancer patients.